Related Experiment Video
Updated: Jan 24, 2026

Surgical Procedures and Methodology for a Preclinical Murine Model of De Novo Mammary Cancer Metastasis
Published on: July 29, 2017
Identifying the murine mammary cell target of metformin exposure
Mona Shehata1, Hyeyeon Kim1, Ravi Vellanki1
1Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7 Canada.
Abstract:
The heterogeneity of breast cancer makes current therapies challenging. Metformin, the anti-diabetic drug, has shown promising anti-cancer activities in epidemiological studies and breast cancer models. Yet, how metformin alters the normal adult breast tissue remains elusive. We demonstrate metformin intake at a clinically relevant dose impacts the hormone receptor positive (HR+) luminal cells in the normal murine mammary gland. Metformin decreases total cell number, progenitor capacity and specifically reduces DNA damage in normal HR+ luminal cells, decreases oxygen consumption rate and increases cell cycle length of luminal cells. HR+ luminal cells demonstrate the lowest levels of mitochondrial respiration and capacity to handle oxidative stress compared to the other fractions, suggesting their intrinsic susceptibility to long-term metformin exposure. Uncovering HR+ luminal cells in the normal mammary gland as the major cell target of metformin exposure could identify patients that would most benefit from repurposing this anti-diabetic drug for cancer prevention/therapy purposes.
Insights
Metformin, an anti-diabetic drug, impacts normal breast tissue by targeting hormone receptor positive (HR+) luminal cells. This study reveals specific cellular changes, suggesting potential for targeted cancer prevention strategies.
Area of Science:
- Oncology
- Endocrinology
- Cell Biology
Background:
- Breast cancer heterogeneity poses therapeutic challenges.
- Metformin exhibits anti-cancer properties in studies.
- The effect of metformin on normal breast tissue is not well understood.
Purpose of the Study:
- To investigate the impact of metformin on normal adult murine mammary gland cells.
- To identify specific cell types targeted by metformin in the mammary gland.
- To explore the potential of metformin for breast cancer prevention.
Main Methods:
- Administration of metformin at a clinically relevant dose to murine models.
- Analysis of cellular changes in different mammary gland cell populations.
- Assessment of cell number, progenitor capacity, DNA damage, oxygen consumption, and cell cycle length.
Main Results:
- Metformin significantly affects hormone receptor positive (HR+) luminal cells in the normal mammary gland.
- Metformin reduces cell number, progenitor capacity, and DNA damage in HR+ luminal cells.
- HR+ luminal cells exhibit reduced oxygen consumption and increased cell cycle length, with lower mitochondrial respiration and oxidative stress handling capacity.
Conclusions:
- HR+ luminal cells are a primary target of metformin in the normal mammary gland.
- The observed effects suggest intrinsic susceptibility of HR+ luminal cells to metformin.
- Identifying this target could refine patient selection for metformin-based cancer prevention or therapy.
More Related Videos
09:04Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
Published on: April 18, 2019
09:59Transfer of Mammary Gland-forming Ability Between Mammary Basal Epithelial Cells and Mammary Luminal Cells via Extracellular Vesicles/Exosomes
Published on: June 3, 2017
Related Concept Videos
The Mammary Glands
Each breast features a pigmented projection known as the nipple, through which milk emerges via closely spaced openings of ducts, referred to as lactiferous ducts. Surrounding the nipple is a circular pigmented area of skin named the areola, which appears rough due to...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Identifying Statistically Significant Differences: The F-Test
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Design Example: Identifying the Locations of Monuments in the Field Using Global Positioning System Device